Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Signs MicroRNA Software Deal With BioDiscovery

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The software development company BioDiscovery and the microRNA analysis and services company Exiqon announced today that they have signed an original equipment manufacturer agreement giving Exiqon the right to include BioDiscovery's array image analysis, data analysis, and visualization software with Exiqon's miRNA arrays.

The partnership will allow users of Exiqon's mirCURY LNA miRNA expression arrays to analyze and visualize miRNA expression patterns using BioDiscovery's Nexus Expression for ImaGene software, which is scanning-platform independent and compatible with a range of operating systems. The software can analyze as many as 24 samples at once, identifying everything from differentially regulated probes to sample clusters.

"The partnership between BioDiscovery and Exiqon provides a complete, well integrated solution for microRNA array studies," BioDiscovery President Soheil Shams said in a statement, noting that the software provides "pre-processing and statistical analysis to identify differentially expressed miRNAs and perform clustering analysis."

Terms of the alliance were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.